High and low dose-rate brachytherapy for cervical carcinoma

Acta Oncologica

Volumn 37, Issue 2, 1998, Pages 117-125

  Orton, Colin G ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; DRUG MEGADOSE; HUMAN; LOW ENERGY RADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; REVIEW; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; CARCINOMA; DOSE FRACTIONATION; FEMALE; HUMANS; RADIOTHERAPY DOSAGE; RISK FACTORS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0031781083     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698429667     Document Type: Review

References (41)

1. Mould RF. Brachytherapy. A century of x-rays and radioactivity in medicine. Bristol: Institute of Physics Publishing. 1993; 126-47.
2. Hilaris BS, Mastores DA, Shih LL, Bodner WR. History of brachytherapy: the years after the discovery of radium and radioactivity. In: Nag S, ed. Principles and practice of brachytherapy. Armonk, New York: Futura Publishing Co. 1997; 13-26.
3. Nag S, Young D, Orton CG. Survey of brachytherapy practice for carcinoma of the cervix in the United States: a report of the American Brachytherapy Society. Int J Radiat Oncol Biol Physics 1997 (submitted for publication).
4. Hashimoto S, Ito H. History and development of HDR afterloading in Japan. Strahlenther Onkol 1988; (Suppl) 82: 10-5.
5. Henschke UK, Hilaris BS, Mahan GD. Afterloading in interstitial and intracavitary radiation therapy. Am J Roentgenol Radium Ther Nucl Med 1963; 90: 386-95.
6. Suit HD, Moore EB, Fletcher GH, Worsnop R. Modification of Fletcher ovoid system for afterloading using standard sized radium tubes. Radiology 1963; 81: 126-31.
7. Fleming JAC, Wiernik G. Fixed source vaginal applicator for irradiation of carcinoma of cervix uteri. Clin Radiol 1963; 14: 28-32.
8. Tazaki E, Arai T, Oryu S. A new applicator for intracavitary irradiation of carcinoma of the uterine cervix. Rinsho-Hosha 1965; 10: 768-75.
9. Henschke UK, Hilaris BS, Mahan GD. Remote afterloading with intracavitary applicators. Radiology 1964; 83: 344-5.
10. O'Connell D, Joslin CA, Howard N, Ramsey NW, Liversage WE. The treatment of uterine carcinoma using the cathetron: part I: technique. Br J Radiol 1967; 40: 882-7.
11. Wakabayashi M. High dose intracavitary radiotherapy using the Ralstron. I: Treatment of carcinoma of the uterine cervix. Nippon Acta Radiol 1971; 31: 340-78.
12. Rotte K. The intracavitary radiation of cervical cancer using an afterloading device with an 192Ir pinpoint source. In: Simon N, ed. Cancer of the uterus in developing areas. Rio de Janeiro. Rockville, Maryland: USDHEW, 1973: 274-82.
13. Glaser FH. Decatron remote afterloading therapy with high activity sources. In: Bates TD, Berry RJ, eds. Special Report No. 17, Br J Radiol 1980; 51-8.
14. AAPM. Remote afterloading technology: AAPM Report No. 41. New York: American Inst of Physics 1993.
15. Walstam R. Remotely controlled afterloading apparatus. Acta Radiol (Ther) 1965; (Suppl 236) Part II.
16. Dusenbery KD, Carson LF, Potish RA. Perioperative morbidity and mortality of gynecologic brachytherapy. Cancer 1991; 67: 2786-90.
17. Orton CG, Ezzell GA. Physics and dosimetry of high dose-rate brachytherapy. In: Principles and practice of radiation oncology. Perez C, Brady L, eds. Philadelphia: Lippincott-Raven, 1997; 473-92.
18. Ljunggren L, Wyman D, Harley L. An assessment of calculated doses in intracavitary gynecologic radiotherapy. Med Dosim 1987; 12: 15-7.
19. King GC, Stockstill TF, Bloomer WD, et al. Point dose variations with time in brachytherapy for cervical carcinoma. Med Phys 1992; 19: 777.
20. Corn BW, Galvin JM, Soffen EM, et al. Positional stability of sources during low-dose-rate brachytherapy for cervical carcinoma. Int J Radiat Oncol Biol Phys 1986; 26: 513-8.
21. Joelsson I, Bäckström A. Dose rate measurements in bladder and rectum. Acta Radiol Ther Phys Biol 1969; 8: 343-59.
22. Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1991; 20: 181-90.
23. Ennow K, Jessen KA. Cost-benefit calculations for high and low dose rate afterloading. Presented at the World Congress on Medical Physics and Biomedical Engineering, Hamburg, 1982.
24. Chenery SGA, Pla M, Podgorsak EB. Physical characteristics of the Selectron high dose rate intracavitary afterloader. Br J Radiol 1985; 58: 735-40.
25. Jones G, Lukka H, O'Brien B. High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysis. Br J Radiol 1994; 67: 1113-20.
26. Bastin K, Buchler D, Stitt J, et al. Comparative cost analysis of high dose rate versus low dose rate brachytherapy for gynecological cancer. Am J Clin Oncol 1993; 16: 256-63.
27. Patel FD, Sharma SC, Negi PS, et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 1994; 28: 335-41.
28. Teshima T, Inoue T, Ikeda H, et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Cancer 1993; 72: 2409-14.
29. Fu KK, Phillips TL. High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1990; 19: 791-6.
30. Orton CG, Seyedsadr M, Somnay S. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991; 21: 1425-34.
31. 192Ir versus conventional radium therapy in cervix cancer: comparison of five-year results and complications. Strahlenther Onkol 1988; (Suppl) 82: 106-13.
32. Vahrson H, Romer G. 5-year results with HDR afterloading in cervix cancer: dependence on fractionation and dose. Strahlenther Onkol 1988; (Suppl) 82: 139-46.
33. Shigematsu Y, Nishiyama K, Masaki N, et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high dose rate: a comparative study with a low-dose system. Int J Radiat Oncol Phys 1983; 9: 351-6.
34. Joslin CAF. High-activity source afterloading a gynecologic cancer and its future prospects. Endocuriether Hyperthermia 1989; 5: 69-81.
35. Wang C-J, Leung SW, Chen H-C, et al. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme. Int J Radiat Oncol Biol Phys 1997; 2: 391-8.
36. Orion CG. Radiobiology. In: Nag S, ed. Principles and practice of brachytherapy. Armonk, NY: Futura Publishing Co. 1997; 27-45.
37. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985; 58: 515-28.
38. Brenner DJ, Hall EJ, Huang Y, Sachs RK. Optimizing the time course of brachytherapy and other accelerated radiotherapeutic protocols. Int J Radiat Oncol Biol Phys 1994; 4: 893-901.
39. Dale RG. The use of small fraction numbers in high dose-rate gynecological afterloading: some radiobiological considerations. Br J Radiol 1990; 63: 290-4.
40. Stitt JA, Fowler JF, Thomadsen BR, et al. High dose rate brachytherapy in carcinoma of the cervix - clinical and biological considerations. Int J Radiat Oncol Biol Phys 1992; 24: 335-48.
41. Brenner DJ, Hall EJ. Fractionated high dose rate versus low dose rate regimens for intracavitary brachytherapy of the cervix. Br J Radiol 1991; 64: 133-41.